Cipla Records ₹76.53 Crore Block Trade on NSE at ₹1,514.40 Per Share

Cipla has recorded a significant block trade on the National Stock Exchange (NSE), highlighting substantial institutional trading activity in the pharmaceutical major's shares. The transaction represents one of the notable block deals in the healthcare sector.

Block Trade Details

The block trade executed on NSE involved considerable volume and value, demonstrating strong institutional interest in Cipla's equity.

Parameter:	Details
Total Transaction Value:	₹76.53 crores
Number of Shares:	~505,366 shares
Price Per Share:	₹1,514.40
Exchange:	National Stock Exchange (NSE)

Market Significance

Block trades represent large-volume transactions typically executed by institutional investors, mutual funds, or other significant market participants. These transactions are conducted through special trading mechanisms designed to handle substantial volumes without causing significant price volatility in the regular market.

The execution price of ₹1,514.40 per share for this transaction indicates the valuation at which institutional participants were willing to transact in Cipla's equity. Such block deals often reflect portfolio rebalancing activities, strategic investments, or divestment decisions by large institutional holders.

Transaction Impact

The block trade involving over 5 lakh shares worth ₹76.53 crores demonstrates the liquidity available in Cipla's stock and the continued interest from institutional investors in the pharmaceutical sector. Block trades of this magnitude typically indicate confidence in the underlying business fundamentals and long-term prospects of the company among sophisticated market participants.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.54%	+1.73%	-0.07%	+0.43%	+1.90%	+83.72%

Cipla Limited has announced the superannuation of Dr Raju Mistry, Global Chief People Officer and Senior Management Personnel, effective December 31, 2025. The announcement was made through a regulatory filing under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Key Details of the Announcement

The pharmaceutical company submitted the disclosure on December 30, 2025, to multiple stock exchanges where its shares are listed. The filing confirms that Dr Mistry will retire from his position as Global Chief People Officer on the last day of 2025.

Parameter:	Details
Officer Name:	Dr Raju Mistry
Position:	Global Chief People Officer
Status:	Senior Management Personnel
Superannuation Date:	December 31, 2025
Successor:	To be announced in due course

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI Listing Regulations, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. This regulation requires listed companies to inform stock exchanges about material events and information that could impact investor decisions.

Stock Exchange Notifications

Cipla submitted the announcement to three exchanges where its securities are traded:

BSE Limited: Scrip Code 500087
National Stock Exchange of India Limited: Scrip Code CIPLA EQ
Societe de la Bourse de Luxembourg: International listing

The company stated that it will announce Dr Mistry's successor in due course, indicating that the transition planning process is underway. The filing was signed by Rajendra Chopra, Company Secretary, and prepared by Pavankumar Yadav.

About the Position

As Global Chief People Officer, Dr Mistry holds a senior management position responsible for human resources strategy and operations across Cipla's global operations. His superannuation marks the end of his tenure in this key leadership role at the pharmaceutical company.